Gubra - Public Comps and Valuation Multiples

Gubra Overview

About Gubra

Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has three segments: Pre-clinical contract research (CRO), which derives maximum revenue; Discovery & Partnerships (D&P) Segment; and Gubra Green Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.

Founded

2008

HQ

Employees

260

Website

gubra.dk

Sectors

Contract Research & Manufacturing
BioTech

Financials

LTM Revenue $312M

LTM EBITDA $254M

EV

$557M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Gubra Financials

As of August 2025, Gubra reported last 12-month revenue of $312M and EBITDA of $254M.

In the same period, Gubra generated $295M in LTM gross profit and $201M in net income.

See Gubra valuation multiples based on analyst estimates

Gubra P&L

In the most recent fiscal year, Gubra reported revenue of $41.5M and EBITDA of -$3.1M.

Gubra expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Gubra valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$312M	XXX	$41.5M	XXX	XXX	XXX
Gross Profit	$295M	XXX	$25.7M	XXX	XXX	XXX
Gross Margin	95%	XXX	62%	XXX	XXX	XXX
EBITDA	$254M	XXX	-$3.1M	XXX	XXX	XXX
EBITDA Margin	82%	XXX	-8%	XXX	XXX	XXX
EBIT	$255M	XXX	-$7.8M	XXX	XXX	XXX
EBIT Margin	82%	XXX	-19%	XXX	XXX	XXX
Net Profit	$201M	XXX	-$5.7M	XXX	XXX	XXX
Net Margin	64%	XXX	-14%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Gubra including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $312M. EBITDA for the last twelve months was $254M. In the most recent fiscal year, Gubra achieved $41.5M in revenue and -$3.1M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$312M	Analyst estimates available to subscribers	$41.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$295M	Analyst estimates available to subscribers	$25.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	94.6% gross margin	Analyst estimates available to subscribers	61.9% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$254M	Analyst estimates available to subscribers	-$3.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	81.6% EBITDA margin	Analyst estimates available to subscribers	-7.5% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$255M	Analyst estimates available to subscribers	-$7.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	81.7% EBIT margin	Analyst estimates available to subscribers	-18.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$201M	Analyst estimates available to subscribers	-$5.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	64.4% net profit margin	Analyst estimates available to subscribers	-13.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Gubra

This financial data table provides comprehensive performance metrics for Gubra, a company based in Denmark. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Gubra generated $312M in revenue over the last twelve months.
The company achieved $254M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $295M.
Net income over the last twelve months reached $201M.

Fiscal Year Performance

In the most recent fiscal year, Gubra reported $41.5M in total revenue.
Fiscal year EBITDA was -$3.1M.
The company maintained a gross profit margin of 61.9% in the most recent fiscal year.
EBITDA margin for the fiscal year was -7.5%.
Net profit margin reached -13.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Gubra. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Gubra Stock Performance

Gubra has current market cap of DKK 6.2B (or $968M), and EV of DKK 3.6B (or $557M).

Market Cap Evolution

Gubra Stock Data

As of September 16, 2025, Gubra's stock price is DKK 379 (or $59).

See Gubra trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$557M	$968M	XXX	XXX	XXX	XXX	$12.62

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Gubra Valuation Multiples

Gubra's trades at 13.4x EV/Revenue multiple, and -177.9x EV/EBITDA.

See valuation multiples for Gubra and 15K+ public comps

Gubra Financial Valuation Multiples

As of September 16, 2025, Gubra has market cap of $968M and EV of $557M.

Equity research analysts estimate Gubra's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Gubra has a P/E ratio of 4.8x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$968M	XXX	$968M	XXX	XXX	XXX
EV (current)	$557M	XXX	$557M	XXX	XXX	XXX
EV/Revenue	1.8x	XXX	13.4x	XXX	XXX	XXX
EV/EBITDA	2.2x	XXX	-177.9x	XXX	XXX	XXX
EV/EBIT	2.2x	XXX	-71.3x	XXX	XXX	XXX
EV/Gross Profit	1.9x	XXX	n/a	XXX	XXX	XXX
P/E	4.8x	XXX	-169.8x	XXX	XXX	XXX
EV/FCF	4.2x	XXX	-131.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Gubra Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Gubra Margins & Growth Rates

Gubra's last 12 month revenue growth is -44%

Gubra's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Gubra's rule of 40 is -57% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Gubra's rule of X is -27% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Gubra and other 15K+ public comps

Gubra Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	-44%	XXX	34%	XXX	XXX	XXX
EBITDA Margin	82%	XXX	-8%	XXX	XXX	XXX
EBITDA Growth	-56%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-57%	XXX	-51%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	-27%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	43%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	81%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial